PT  - JOURNAL ARTICLE
AU  - Gao, Jing
AU  - Wang, Zhengyi
AU  - Jiang, Wenqing
AU  - Zhang, Yanni
AU  - Meng, Zhen
AU  - Niu, Yanling
AU  - Sheng, Zhen
AU  - Chen, Chan
AU  - Liu, Xuejun
AU  - Chen, Xi
AU  - Liu, Chanjuan
AU  - Jia, Keren
AU  - Zhang, Cheng
AU  - Liao, Haiyan
AU  - Jung, Jaeho
AU  - Sung, Eunsil
AU  - Chung, Hyejin
AU  - Zhang, Jingwu Z.
AU  - Zhu, Andrew X.
AU  - Shen, Lin
TI  - CLDN18.2 and 4-1BB bispecific antibody givastomig exerts antitumor activity through CLDN18.2-expressing tumor-directed T-cell activation
AID  - 10.1136/jitc-2023-006704
DP  - 2023 Jun 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e006704
VI  - 11
IP  - 6
4099  - http://jitc.bmj.com/content/11/6/e006704.short
4100  - http://jitc.bmj.com/content/11/6/e006704.full
SO  - J Immunother Cancer2023 Jun 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.